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Determing what is cost-effective quality care. What is the 
most cost-effective management of patients after acute myo- 
cardial infarction? Should all such patients undergo cathe- 
terization? Should noninvasive tests be used to determine 
candidates for catheterization? If so, which noninvasive test 
is best? Unfortunately, at this time, there are no uniformly 
accepted answers to these questions. Each of us arrives at 
our answers based on our continuing education, experience 
and what we perceive to be best for that individual patient. 
Our choices, however, are increasingly restricted. 
Concern with cost has become the driving force behind 
health policy, and will continue to do so for the foreseeable 
future. Reimbursement decisions and policies by those con- 
trolling the purse strings are based primarily on cost con- 
tainment and hope; hope that these reimbursement decisions 
will reduce costs by eliminating “inefficiency,” while main- 
taining access and quality. At present, our profession is 
being asked to determine what is “efficient” and what is 
quality care, and nowhere is the challenge greater than in the 
cardiovascular area with its high volume, high cost technol- 
ogy. I suspect that there are few of us willing to see others 
assume this role, yet we currently are ill-prepared to fulfill 
this task. We can, by consensus, generally arrive at what we 
believe is quality care, but frequently disagree as to what is 
the most efficient or cost-effective care of a particular 
problem. 
Fortunately, we do have powerful tools with which to 
attack our problems. As is evident from this Symposium, 
clinical decision modeling can provide us with data on cost 
effectiveness with which to approach health policy decision- 
makers and reimbursers. Costly procedures need to be 
justified or replaced by less costly alternatives based on 
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scientific data rather than our impressions or someone’s 
desire to reduce costs. 
Role of the American College of Cardiology in the use of 
decision modeling. The American College of Cardiology long 
has been involved in ensuring quality cardiovascular care. 
Through our Committees on Technology Assessment, Med- 
ical Devices, Cardiac Pacemakers, Electrophysiologyl 
Electrocardiography, Echocardiography and Cardiovascular 
Imaging as well as our joint American College of Cardiology/ 
American Heart Association Task Force on Cardiovascular 
Procedures and Bethesda conferences, issues of quality care 
have been addressed. Our Government Relations Committee 
and, recently formed, Private Sector Relations and Econom- 
ics of Health Care Delivery Committees have and will 
continue to work with regulatory agencies and third party 
carriers regarding quality of care issues. Yet, it became 
apparent that our opinions expressed without supporting 
data were increasingly challenged, particularly in the area of 
cost-effective cardiovascular care. Thus, under the leader- 
ship of Dr. Suzanne Knoebel and our Cardiovascular Norms 
Committee, we have been actively involved in the develop- 
ment of cost-effective strategies for cardiovascular care, 
using scientific data derived from decision modeling. The 
Presidential Address at the Opening Plenary Session of our 
Annual Scientific Meeting in 1985 was devoted to the impor- 
tance of decision modeling in protecting high quality care. 
Our Computer Applications Committee has had an exhibit at 
several of our Annual Scientific Sessions, demonstrating the 
use of decision modeling in clinical practice. We are cur- 
rently considering how to best increase our activities in the 
area because we see decision modeling as the means for 
obtaining the information needed to protect high quality 
cost-effective cardiovascular care. 
Questions for the future. There may however, be signifi- 
cant impediments to the general and effective application of 
these techniques. Is the necessary patient data base avail- 
able? If not, can it be obtained? Can we marshal1 the 
resources and develop the organizational structure neces- 
sary to produce the data? Can we use the data to affect 
health policy? These impediments are not insurmountable. 
Many of the leaders in decision modeling have participated 
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in this meeting, and their expertise and enthusiasm are zations, through their previously established relations with 
evident. Organizations such as the American College of those determining health policy, can then use this informa- 
Cardiology can bring together those with the expertise and tion to attain what we all desire: high quality cost-effective 
those with the necessary data to facilitate the development care. The American College of Cardiology looks forward to 
of scientifically based cost-effective strategies. Such organi- its continued role as an active participant in this endeavor. 
